| LINE ITEM (USD / %) | FY 2025
FILED 2026-01-03 | FY 2024
FILED 2024-12-28 | FY 2023
FILED 2023-12-30 |
|---|---|---|---|
| Revenue (Total Sales) | $1.00B | $1.14B | $1.41B |
| YoY Revenue Growth % | -12.3% | -18.9% | — |
| Gross Profit | $563.1M | $597.2M | — |
| Gross Margin % | 56.1% | 52.2% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$19.1M | -$103.9M | -$143.0M |
| Operating Margin % | -1.9% | -9.1% | -10.1% |
| Net Income (GAAP) | $0 | $0 | $0 |
| EBITDA (Normalized) | -$17.0M | -$98.5M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$57.9M | $46.7M | -$59.5M |
| Capital Expenditures (CapEx) | $2.6M | $6.8M | — |
| Free Cash Flow (FCF) | -$60.5M | $39.9M | -$59.5M |
| FCF Margin % | -6.0% | 3.5% | -4.2% |
| Return on Invested Capital (ROIC %) | -7.2% | -43.0% | — |
| Cash & Short-Term Equivalents | $95.8M | $123.6M | — |
| Total Debt (Short + Long Term) | $201.1M | $165.9M | — |
| Total Stockholders' Equity | $102.8M | $148.7M | — |